Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients

Transplant Proc. 2000 May;32(3):580-2. doi: 10.1016/s0041-1345(00)00898-8.

Authors

M Gürsoy¹, R Köksal, D Karavelioğlu, T Colak, G Gür, N Ozdemir, S Boyacioğlu, N Bilgin

Affiliation

¹ Başkent University Faculty of Medicine, Departments of Gastroenterology, Nephrology, and General Surgery, Ankara, Turkey.

PMID: 10812121
DOI: 10.1016/s0041-1345(00)00898-8

No abstract available

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Female
Graft Survival
Hepatitis C / drug therapy*
Hepatitis C / physiopathology
Humans
Interferon-alpha / therapeutic use*
Kidney Transplantation*
Male
Preoperative Care*
Survival Analysis
Transplantation, Homologous

Substances

Antiviral Agents
Interferon-alpha